Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

9,012 public trials 1,844 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

NCT05653271

Conditions
B-cell Lymphoma, Burkitt Lymphoma, DLBCL, +23 more
Locations
  • AdventHealth Orlando Orlando, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Indiana University Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
View all 13 locations
View Trial Details
Completed

Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL

NCT04168788

Conditions
Acute Lymphoblastic Leukemia, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +30 more
Locations
  • Univesity Hostipal of Amiens Amiens, France
  • University Hospital of Bordeaux Bordeaux, France
  • University of Brest Brest, France
  • Centre Oscar Lambret Lille, France
View Trial Details
Completed

HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903

NCT04975698

Conditions
HIV Associated Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Georgetown Washington D.C., District of Columbia, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Northside Atlanta, Georgia, United States
View Trial Details
Completed

Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER)

NCT05455931

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • The Johns Hopkins University School of Medicine Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Colombia University Medical Center New York, United States
  • Inova Dwight and Martha Schar Cancer Institute Fairfax, Virginia, United States
View all 19 locations
View Trial Details
Completed

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)

NCT02393859

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Site Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • Research Site Randwick, New South Wales, Australia
  • Research Site Westmead, New South Wales, Australia
  • Research Site South Brisbane, Queensland, Australia
View all 103 locations
View Trial Details

Related conditions